On the stock market since 2016, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
The stock trades 31% below its peak. The market has trimmed its expectations for the company.
It pays out $0.24 per share each year — regular cash for whoever holds the stock.
A loss of $6.1M against -$5.8M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
Over the last 12 months, executives reported 6 sells against just 0 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, IHIT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: IHIT is a high-risk stock — not yet profitable, and its future rides on its product catching on.